Fuan Pharmaceutical Group Co., Ltd. (300194)
Market Closed
11 Aug, 06:57
XSHE XSHE Primary ¥
3. 89
0
0%
¥
5.37B Market Cap
- P/E Ratio
0.08% Div Yield
25.6M Volume
- Eps
¥ 3.89
Previous Close Want to track 300194 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summary
300194 closed today higher at ¥3.89, an increase of 0% from yesterday's close, completing a monthly increase of 15.4303% or ¥0.52. Over the past 12 months, 300194 stock lost -11.991%.
300194 pays dividends to its shareholders, with the most recent payment made on May 28, 2026. The next estimated payment will be in In 3 months on Nov 28, 2026 for a total of ¥0.05.
The last earnings report, released on May 23, 2025, exceeded the consensus estimates by 0.058%. On average, the company has surpassed earnings expectations by 0.0775%, based on the last three reports.
Fuan Pharmaceutical Group Co., Ltd. has completed 3 stock splits, with the recent split occurring on May 10, 2017.
The company's stock is traded on one exchange.
Fuan Pharmaceutical Group Co., Ltd. (300194) FAQ
What is the stock price today?
The current price is ¥3.89.
On which exchange is it traded?
Fuan Pharmaceutical Group Co., Ltd. is listed on XSHE.
What is its stock symbol?
The ticker symbol is 300194.
Does it pay dividends? What is the current yield?
Yes, It pays dividends and the current yield is 0.08%.
What is its market cap?
As of today, the market cap is 5.37B.
Has Fuan Pharmaceutical Group Co., Ltd. ever had a stock split?
Fuan Pharmaceutical Group Co., Ltd. had 3 splits and the recent split was on May 10, 2017.
Fuan Pharmaceutical Group Co., Ltd. Profile
| Specialty Retail Industry | Consumer Discretionary Sector | Mr. Lu Wang CEO | XSHE Exchange | CNE1000011G4 ISIN |
| CN Country | 3,392 Employees | 28 May 2026 Last Dividend | 10 May 2017 Last Split | 22 Mar 2011 IPO Date |
Overview
Fuan Pharmaceutical (Group) Co., Ltd. is a prominent entity in the pharmaceutical industry located in the People's Republic of China. Founded in 2004, initially as Chongqing Fuan Pharmaceutical (Group) Co., Ltd., the company underwent a name change in August 2013 to its current designation. Operating from its headquarters in Chongqing, Fuan Pharmaceutical focuses on the research, development, production, and sales of chemical drugs within the Chinese market. Its comprehensive operations span across various subsidiaries, underscoring its expansive reach and significant impact on the pharmaceutical sector in China.
Products and Services
Fuan Pharmaceutical (Group) Co., Ltd. extends a diverse array of pharmaceutical products and services, ensuring to meet various medical and therapeutic needs. These include:
- APIs (Active Pharmaceutical Ingredients): These are the essential substances in medications that offer therapeutic benefits. Fuan Pharmaceutical specializes in the production of high-quality APIs, catering to a broad range of pharmaceutical formulations.
- Intermediates: Serving as critical components in drug manufacturing, intermediates are substances produced during the steps of the synthesis of APIs. Fuan Pharmaceutical provides various intermediates, facilitating the production of complex APIs.
- FFPs (Finished Formulation Products): The company's portfolio also includes a comprehensive range of finished dosage forms, such as:
- Anti-tumor medications: These are specialized drugs designed for the treatment of cancer, showcasing Fuan Pharmaceutical’s commitment to combating oncological diseases.
- Antibiotics and oral medications: Addressing infections and other health conditions, the company produces a variety of antibiotics and oral drugs, essential for both acute and chronic healthcare treatments.
- Freeze-drying preparation for injection: Fuan Pharmaceutical offers advanced freeze-dried products for injection, ensuring stability and efficacy of drugs, particularly useful in emergency medicine and other critical care scenarios.
Contact Information
Address: No. 2, Huangyang Road, Chongqing, China, 401121
Phone: 86 23 6121 3011
Website: https://www.fapharm.com
